India, Aug. 5 -- Panacea Biotec has received a Letter of Award from UNICEF for the supply of bivalent Oral Polio Vaccine (bOPV) worth approximately US$8.205 million (around Rs 78.24 crore) for Calendar Year 2028.
The latest order is part of the company's previously announced Long-Term Agreement with UNICEF, under which Panacea Biotec will supply 10-dose and 20-dose presentations of bOPV from April 1, 2026, to March 31, 2030.
The award further strengthens the company's order pipeline under the long-term contract and reinforces its position as a key global supplier of polio vaccines.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....